Fagron’s share buy-back program: Weekly update

Group 1 - Fagron has initiated a share buy-back program, purchasing 20,000 shares at an average price of €20.609, totaling €412,180 from 16 October 2025 to 17 October 2025 [1] - The share buy-back program aims to fulfill obligations under Fagron's long-term incentive scheme, with a total of up to 200,000 shares planned for repurchase [1] - To date, Fagron has purchased a total of 20,000 shares under this program [1] Group 2 - Fagron is a global leader in pharmaceutical compounding, providing personalized medicine to hospitals, pharmacies, clinics, and patients in over 30 countries [3] - The company is registered in Belgium and listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR' [4] - Operational activities are managed by Fagron BV, headquartered in Rotterdam, Netherlands [4]